Clinical and pathophysiological consequences of abdominal adiposity and abdominal adipose tissue depots

Nutrition

Volumn 19, Issue 5, 2003, Pages 457-466

  Misra, Anoop ^a,b   Vikram, Naval K ^a  

^a ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

Abdominal obesity; Adipocytes; Body fat; Hyperlipidemia; Insulin resistance syndrome; Type 2 diabetes mellitus; Visceral fat

Indexed keywords

ANGIOTENSIN; CATECHOLAMINE; CYTOKINE; GLUCOSE; INSULIN; LEPTIN; PLASMINOGEN ACTIVATOR INHIBITOR 1; RECEPTOR; RENIN;

ABDOMEN; ABDOMINAL OBESITY; ADIPOCYTE; ADIPOSE TISSUE; ATHEROGENESIS; BIOCHEMISTRY; BODY FAT; CARDIOVASCULAR RISK; CELL GROWTH; CELL SIZE; CORRELATION ANALYSIS; DYSLIPIDEMIA; ENDOTHELIUM; ETHNOLOGY; GLUCOSE INTOLERANCE; GLUCOSE METABOLISM; HORMONE ACTION; HORMONE SENSITIVITY; HUMAN; HYPERCOAGULABILITY; HYPERTENSION; INSULIN RESISTANCE; LIPID METABOLISM; LIPOLYSIS; LOW BIRTH WEIGHT; MEDLINE; METABOLISM; MOLECULAR BIOLOGY; OBESITY; PATHOGENESIS; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROGNOSIS; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; REVIEW; SCISEARCH; SUBCUTANEOUS FAT; UNITED STATES;

ABDOMEN; ADIPOSE TISSUE; BODY COMPOSITION; BODY CONSTITUTION; CARDIOVASCULAR DISEASES; DIABETES MELLITUS, TYPE 2; HUMANS; OBESITY; RISK FACTORS;

EID: 0037403774     PISSN: 08999007     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0899-9007(02)01003-1     Document Type: Review

References (171)

1. Kuczmarski R.J., Flegal K.M., Campbell S.M., Johnson C.L. Increasing prevalence of overweight amongst US adults the National Health and Nutrition Examination Surveys, 1960 to 1991. JAMA. 274:1994;205.
2. Wilson B.D., Wilson N.C., Russel D.G. Obesity and body fat distribution in the New Zealand population. N Z Med J. 114:(1128):2001;127.
3. Vague J. The degree of masculine differentiation of obesities a factor determining predisposition to diabetes, atherosclerosis, gout, and uric calculus disease. Am J Clin Nutr. 4:1956;20.
4. Ashwell M., Chinn S., Stalley S., Garrow J.S. Female fat distribution - a simple classification based on two circumference measures. Int J Obes. 6:(2):1982;143.
5. Nutrition and your health: dietary guidelines for Americans. 3rd ed. 1990;US Government Printing Office, Washington, DC. Home and garden bulletin no. 232.
6. Despres J.P., Lemieux I., Prud'homme D. Treatment of obesity need to focus on high risk abdominally obese patients. BMJ. 322:2001;716.
7. Armellini F., Zamboni M., Rigo L., et al. Sonography detection of small intra-abdominal fat variations. Int J Obes. 15:(12):1991;847.
8. Kamel E.G., McNeill G., Han T.S., et al. Measurement of abdominal fat by magnetic resonance imaging, dual-energy X-ray absorptiometry and anthropometry in non-obese men and women. Int J Obes Relat Metab Disord. 23:(7):1999;686.
9. Lemieux S., Prud'homme D., Tremblay A., Bouchard C., Despres J.P. Anthropometric correlates to changes in visceral adipose tissue over 7 years in women. Int J Obes Relat Metab Disord. 20:1996;618.
10. Pouliot M.C., Despres J.P., Lemieux S., et al. Waist circumference and abdominal sagittal diameter best simple anthropometric indexes of abdominal visceral adipose tissue accumulation and related cardiovascular risk in men and women. Am J Cardiol. 73:1994;460.
11. Schreiner P.J., Terry J.G., Evans G.W., et al. Sex-specific associations of magnetic resonance imaging-derived abdominal and subcutaneous fat areas with conventional anthropometric indices. The Atherosclerosis Risk in Communities Study. Am J Epidemiol. 144:(4):1996;335.
12. Lean M.E., Han T.S., Durenberg P. Predicting body composition by densitometry from simple anthropometric measurements. Am J Clin Nutr. 63:1996;4.
13. Dobbelsteyn C.J., Joffres M.R., MacLean D.R., Flowerdew G. A comparative evaluation of waist circumference, waist-to-hip ratio and body mass index as indicators of cardiovascular risk factors. The Canadian Heart Health Surveys. Int J Obes Relat Metab Disord. 25:(5):2001;652.
14. Okosun I.S., Liao Y., Rotimi C.N., Prewitt T.E., Cooper R.S. Abdominal obesity and clustering of multiple metabolic syndrome in Black and Hispanic population. Ann Epidemiol. 10:(5):2000;263.
15. Patel S., Unwin N., Bhopal R., et al. A comparison of proxy measures of obesity in Chinese, European, and South Asian adults. Diabet Med. 16:1999;853.
16. Lean M.E., Han T.S., Morrison C.E. Waist circumference as a measure for indicating need for weight management. BMJ. 311:(6998):1995;158.
17. Okosun I.S., Prewitt T.E., Cooper R.S. Abdominal obesity in United States prevalence and attributable risk of hypertension. J Hum Hypertens. 13:(7):1999;425.
18. Okosun I.S., Rotimi C.N., Forrester T.E., et al. Predictive value of abdominal obesity cut-off points for hypertension in blacks from West African and Caribbean Island nations. Int J Obes Relat Metab Disord. 24:(2):2000;180.
19. McNeely M.J., Boyko E.J., Shofer J.B., et al. Standard definitions of overweight and central adiposity for determining diabetes risk in Japanese Americans. Am J Clin Nutr. 74:(1):2001;101.
20. World Health Organization. The Asia-Pacific perspective. Redefining obesity and its treatment. International Diabetes Institute, Health Communications Australia Pty Limited 2000, www.obesityasiapacific.com.
21. Seidell J.C., Han T.S., Feskens E.J., Lean M.E. Narrow hips and broad waist circumferences independently contribute to increased risk of non-insulin dependent diabetes mellitus. J Int Med. 242:1997;401.
22. Chowdhury B., Lantz H., Sostrom L. Computed tomography-determined body composition in relation to cardiovascular risk factors in Indians and matched Swedish males. Metabolism. 45:1996;634.
23. Seidell J.C., Perusse L., Despres J.P., Bouchard C. Waist and hip circumferences have independent and opposite effects on cardiovascular disease risk factors the Quebec Family Study. Am J Clin Nutr. 74:(3):2001;315.
24. Han T.S., Bijnen F.C., Lean M.E., Seidell J.C. Separate associations of waist and hip circumferences with lifestyle factors. Int J Epidemiol. 27:(3):1998;422.
25. Haffner S.M., Stern M.P., Hazuda H.P., et al. Upper body and centralized obesity in Mexican American and non-Hispanic whites relationship to body mass index and other behavioral and demographic variables. Int J Obes. 10:(6):1986;493.
26. Haffner S.M., Stern M., Hazuda H.P., Pugh J., Patterson J.K. Do upper-body and centralized adiposity measure different aspects of regional body-fat distribution? Relationships to non-insulin-dependent diabetes mellitus, lipids and lipoproteins. Diabetes. 36:1987;43.
27. Bjorntorp P. "Portal" adipose tissue as a generator of risk factors for cardiovascular disease and diabetes. Arteriosclerosis. 10:1990;493.
28. Guo Z., Hensrud D.D., Johnson C.M., Jensen M.D. Regional post-prandial fatty acid metabolism in different obesity phenotypes. Diabetes. 48:1999;1586.
29. Unger R.H. Lipotoxicity in the pathogenesis of obesity-dependent NIDDM. Genetic and clinical implications. Diabetes. 44:1995;863.
30. Kobayashi H., Nakamura T., Miyaoka K., et al. Visceral fat accumulation contributes to insulin resistance, small-sized low-density lipoprotein, and progression of coronary artery disease in middle-aged non-obese Japanese men. Jpn Circ J. 65:(3):2001;193.
31. Couillard C., Bergeron N., Prud'homme D., et al. Gender difference in postprandial lipemia importance of visceral adipose tissue accumulation. Arterioscler Thromb Vasc Biol. 19:1999;2448.
32. Mekki N., Christofilis M.A., Charbonnier M., et al. Influence of obesity and body fat distribution on postprandial lipemia and triglyceride-rich lipoproteins in adult women. J Clin Endocrinol Metab. 84:1999;184.
33. Perseghin G., Ghosh S., Gerow K., Shulman G.I. Metabolic defects in lean nondiabetic offspring of NIDDM parents a cross-sectional study. Diabetes. 46:1997;1001.
34. Alessi M.C., Peiretti F., Morange P., et al. Production of plasminogen activator inhibitor 1 by human adipose tissue-possible link between visceral fat accumulation and vascular disease. Diabetes. 46:1997;860.
35. Mertens I., Van der Planken M., Corthouts B., et al. Visceral fat is a determinant of PAI-1 activity in diabetic and non-diabetic overweight and obese women. Horm Metab Res. 33:(10):2001;602.
36. Lemieux I., Pascot A., Prud'homme D., et al. Elevated C-reactive protein another component of the atherothrombotic profile of abdominal obesity. Arterioscler Thromb Vasc Biol. 21:(6):2001;961.
37. Forouhi N.G., Sattar N., McKeigue P.M. Relation of C-reactive protein to body fat distribution and features of the metabolic syndrome in Europeans and South Asians. Int J Obes Relat Metab Disord. 25:2001;1327.
38. Chambers J.C., Eda S., Bassett P., et al. C-reactive protein, insulin resistance, central obesity, and coronary heart disease risk in Asians from United Kingdom compared with European whites. Circulation. 104:(2):2001;145.
39. Hashimoto M., Akishita M., Eto M., et al. The impairment of flow-mediated vasodilatation in obese men with visceral fat accumulation. Int J Obes Relat Metab Disord. 22:1998;477.
40. Brook R.D., Bard R.L., Rubenfire M., Ridker P.M., Rajagopalan S. Usefulness of visceral obesity (waist/hip ratio) in predicting vascular endothelial function in healthy overweight adults. Am J Cardiol. 88:2001;1264.
41. Carey V.J., Walters E.E., Colditz G.A., et al. Body fat distribution and risk of non-insulin dependent diabetes mellitus. The Nurses Health Study. Am J Epidemiol. 145:1997;614.
42. Okosun I.S., Chandra K.M., Choi S., et al. Hypertension and type 2 diabetes comorbidity in adults in United States risk of overall and regional adiposity. Obes Res. 9:2001;1.
43. Wat N.M., Lam T.H., Janus E.D., Lam K.S. Central obesity predicts the worsening of glycemia in southern Chinese. Int J Obes Relat Metab Disord. 25:2001;1789.
44. Han T.S., Feskens E.J., Lean M.E., Seidell J.C. Associations of body composition with type 2 diabetes mellitus. Diabet Med. 15:(2):1998;129.
45. Ko G.T., Chan J.C., Cockram C.S. The association between dyslipidemia and obesity in Chinese men after adjustment for insulin resistance. Atherosclerosis. 138:1998;153.
46. Lemieux I., Pascot A., Couillard C., et al. Hypertriglyceridemic waist A marker of the atherogenic metabolic triad (hyperinsulinemia; hyperapolipoprotein B; small dense LDL) in men. Circulation. 102:2000;179.
47. Harris M.M., Stevens J., Thomas N., Schreiner P., Folsom A.R. Association of fat distribution and obesity with hypertension in a bi-ethnic population the ARIC Study. Atherosclerosis Risk in Communities Study. Obes Res. 8:2000;516.
48. Kortelainen M.L., Srakioja T. Extent and composition of coronary lesions and degree of cardiac hypertrophy in relation to abdominal fatness in men under 40 years of age. Arterioscler Thromb Vasc Biol. 17:(3):1997;574.
49. Kortelainen M.L., Srakioja T. Visceral fat and coronary pathology in male adolescents. Int J Obes Relat Metab Disord. 25:2001;228.
50. Planas A., Clara A., Pou J.M., et al. Relationship of obesity distribution to peripheral arterial occlusive disease in elderly men. Int J Obes Relat Metab Disord. 25:2001;1068.
51. Mulyadi L., Stevens C., Munro S., Lingard J., Bermingham M. Body fat distribution and total fat as risk factors for microalbuminuria in the obese. Ann Nutr Metab. 45:2001;67.
52. Misra A. Risk factors for atherosclerosis in young individuals. J Cardiovasc Risk. 7:2000;215.
53. Caprio S., Hyman L.D., McCarthy S., et al. Fat distribution and cardiovascular risk factors in obese adolescent girls importance of intra-abdominal fat depot. Am J Clin Nutr. 64:1996;12.
54. Enzi G., Gasparo M., Biondetti P.R., et al. Subcutaneous and visceral fat distribution according to sex, age, and overweight, evaluated by computed tomography. Am J Clin Nutr. 44:1986;739.
55. Matsuzawa Y., Nakamura T., Shimomura I., Kotani K. Visceral fat accumulation and cardiovascular disease. Angel A., Anderson H., Bouchard C., et al. Progress in obesity research, Vol 7. Proceedings of the Seventh International Congress on Obesity, Toronto, Canada, August 20-25, 1994. 1996;569 John Libbey and Co, Toronto.
56. Zamboni M., Armellini F., Muller D., et al. Methodological and clinical aspects of subcutaneous fat distribution. Angel A., Anderson H., Bouchard C., et al. Progress in obesity research, Vol 7. Proceedings of the Seventh International Congress on Obesity, Toronto, Canada, August 20-25, 1994. 1996;145 John Libbey and Co, Toronto.
57. Tchernof A., Depress J.P. Sex steroid hormones, sex-hormone binding globulin, and obesity in men and women. Horm Metab Res. 32:(11-12):2000;526.
58. Tchernof A., Calles-Escandon J., Sites C.K., et al. Menopause, central body fatness, and insulin resistance effects of hormone replacement therapy. Coron Artery Dis. 9:(8):1998;503.
59. Johannsson G., Marin P., Lonn L., et al. Growth hormone treatment of abdominally obese men reduces abdominal fat mass, improves glucose and lipoprotein metabolism, and reduces diastolic blood pressure. J Clin Endocrinol Metab. 82:1997;727.
60. Casanueva F.F., Dieguez C. Interaction between body composition, leptin and growth hormone status. Baillieres Clin Endocrinol Metab. 12:(20):1998;297.
61. Seidell J.C., Visscher T.L. Body weight and weight change and health implications for the elderly. Eur J Clin Nutr. 54:(suppl 3):2000;S33.
62. Beaufrere B., Morio B. Fat and protein distribution in aging metabolic considerations. Eur J Clin Nutr. 54:(suppl 3):2000;S48.
63. Lemieux S., Prud'homme D., Bouchard C., Tremblay A., Despres J.P. Sex differences in the relation of visceral adipose tissue accumulation to total body fatness. Am J Clin Nutr. 58:1993;463.
64. Okosun I.S. Ethnic differences in the risk of type 2 diabetes attributable to differences in abdominal adiposity in American women. J Cardiovasc Risk. 7:(6):2000;425.
65. Okosun I.S., Choi S., Dent M.M., Jobin T., Dever G.E. Abdominal obesity defined as larger than expected waist girth is associated with racial/ethnic differences in risk of hypertension. J Hum Hypertens. 15:(5):2001;307.
66. Despres J.P., Couillard C., Gagnon J., et al. Race, visceral adipose tissue, plasma lipids, and lipoprotein lipase activity in men and women the Health, Risk Factors, Exercise Training and Genetics (HERITAGE) Family Study. Arterioscler Thromb Vasc Biol. 20:(8):2000;1932.
67. McKeigue P.M., Pierpoint T., Ferrie J.E., Marmot M.G. Relationship of glucose intolerance and hyperinsulinaemia to body fat pattern in south Asians and Europeans. Diabetologia. 35:(8):1992;785.
68. McKeigue P.M., Shah B., Marmot M.G. Relation of central obesity and insulin resistance with high diabetes prevalence and cardiovascular risk in South Asians. Lancet. 337:(8738):1991;382.
69. Whincup P.H., Gilg J.A., Papacosta O., et al. Early evidence of ethnic differences in cardiovascular risk cross sectional comparison of British South Asian and white children. BMJ. 324:(7338):2002;635.
70. Bavdekar A., Yajnik C.S., Fall C.H., et al. Insulin resistance syndrome in 8-year-old Indian children small at birth, big at 8 years, or both? Diabetes. 48:1999;2422.
71. Misra A., Pandey R.M., Devi J.R., et al. High prevalence of diabetes, obesity and dyslipidemia in urban slum population in northern India. Int J Obes. 25:2001;1722.
72. Misra A., Sharma R., Pandey R.M., Khanna N. Adverse profile of dietary nutrients, anthropometry and lipids in urban slum dwellers of northern India. Eur J Clin Nutr. 55:2001;727.
73. Misra A., Athiko D., Sharma R., Pandey R.M., Khanna N. Non-obese hyperlipidemic Asian northern Indians males have adverse anthropometric profile. Nutr Metab Cardiovasc Dis. 2002;. (in press).
74. Banerji M.A., Faridi N., Atluri R., Chaiken R.L., Lebovitz H.E. Body composition, visceral fat, leptin, and insulin resistance in Asian Indian men. J Clin Endocrinol Metab. 84:1999;137.
75. Dudeja V., Misra A., Pandey R.M., et al. Body mass index does not accurately predict overweight in Asian Indians in Northern India. Br J Nutr. 86:2001;105.
76. Vikram N.K., Misra A., Pandey R.M. Anthropometry and body composition in northern Asian Indian patients with type 2 diabetes receiver operating characteristics (ROC) curve analysis of body mass index with percentage body fat as standard. Diabetes Nutr Metab. 2002;. (in press).
77. Raji A., Seely E.W., Arky R.A., Simonson D.C. Body fat distribution and insulin resistance in healthy Asian Indians and Caucasians. J Clin Endocrinol Metab. 86:2001;5366.
78. Pais P., Pogue J., Gerstein H., et al. Risk factors for acute myocardial infarction in Indians a case-control study. Lancet. 348:(9024):1996;358.
79. Mohan V., Shanthirani S., Deepa R., et al. Intra-urban differences in the prevalence of the metabolic syndrome in southern India - the Chennai Urban Population Study (CUPS no. 4). Diabet Med. 18:(4):2001;280.
80. Misra A., Chaudhary D., Vikram N.K., et al. Insulin resistance and clustering of atherogenic risk factors in women belonging to low socio-economic strata in urban slums of North India. Diabetes Res Clin Pract. 56:2002;73.
81. Hughes K., Aw T.C., Kuperan P., Choo M. Central obesity, insulin resistance, syndrome X, lipoprotein(a), and cardiovascular risk in Indians, Malays, and Chinese in Singapore. J Epidemiol Community Health. 51:(4):1997;394.
82. Dowse G.K., Zimmet P.Z., Gareeboo H., et al. Abdominal obesity and physical inactivity as risk factors for NIDDM and impaired glucose tolerance in Indian, Creole, and Chinese Mauritians. Diabetes Care. 14:1991;271.
83. Ford E.S., Giles W.H., Dietz W.H. Prevalence of the metabolic syndrome among US adults findings from the Third National Health and Nutrition Examination Survey. JAMA. 287:2002;356.
84. Casas Y.G., Schiller B.C., DeSouza C.A., Seals D.R. Total and regional body composition across age in healthy Hispanic and white women of similar socioeconomic status. Am J Clin Nutr. 73:2001;13.
85. Yajnik C.S. Interactions of perturbations in intrauterine growth and growth during childhood with the risk of adult-onset disease. Proc Nutr Soc. 59:(2):2002;257.
86. Choi C.S., Kim C., Lee W.J., et al. Association between birth weight and insulin sensitivity in healthy young men in Korea; role of visceral adiposity. Diabetes Res Clin Pract. 49:(1):2000;53.
87. Ong K.K., Ahmed M.L., Emmett P.M., et al. Association between postnatal catch-up growth and obesity in childhood prospective cohort study. BMJ. 320:(7240):2000;967.
88. Byberg L., McKeigue P.M., Zethelius B., Lithell H.O. Birth weight and the insulin resistance syndrome association of low birth weight with truncal obesity and raised plasminogen activator inhibitor-1 but not with abdominal obesity or plasma lipid disturbances. Diabetologia. 43:2000;54.
89. Leeson C.P., Kattenhorn M., Morley R., Lucas A., Deanfield J.E. Impact of low birth weight and cardiovascular risk factors on endothelial function in early adult life. Circulation. 103:2001;1264.
90. Sawaya A.L., Grillo L.P., Verreschi I., da Silva A.C., Roberts S.B. Mild stunting is associated with higher susceptibility to the effects of high fat diets studies in a shantytown population in Sao Paulo, Brazil. J Nutr. 128:(suppl):1998;415S.
91. Chowdhury B., Sjostrom L., Alpsten M., et al. Multicompartment body composition technique based on computerized tomography. Int J Obes. 18:1994;219.
92. Sardinha L.B., Teixeira P.J., Guedes D.P., et al. Subcutaneous central fat is associated with cardiovascular risk factors in men independent of total fatness and fitness. Metabolism. 49:2000;1379.
93. Abate N., Burns D., Peshock R.M., et al. Estimation of adipose tissue mass by magnetic resonance imaging validation against dissection in human cadavers. J Lipid Res. 35:1994;1490.
94. Abate N., Garg A., Peshock R.M., et al. Relationships of generalized and regional adiposity to insulin sensitivity in men. J Clin Invest. 96:1995;88.
95. Goodpaster B.H., Thaete F.L., Simoneau J.A., et al. Subcutaneous abdominal fat and thigh muscle composition predicts insulin sensitivity independently of visceral fat. Diabetes. 46:1997;1579.
96. Tai E.S., Lau T.N., Ho S.C., et al. Body fat distribution and cardiovascular risk in normal weight women. Association with insulin resistance, lipids and plasma leptin. Int J Obes Relat Metab Disord. 24:(6):2000;751.
97. Misra A., Garg A., Abate N., et al. Subcutaneous anterior and posterior abdominal adipose tissue mass and its relation to insulin sensitivity. Obes Res. 5:1997;93.
98. Anderson D.B., Kauffman R.G. Cellular and enzymatic changes in porcine adipose tissue during growth. J Lipid Res. 14:1973;160.
99. Arner P., Engfeldt P., Lithell H. Site differences in the basal metabolism of subcutaneous fat in obese women. J Clin Endocrinol Metab. 53:1981;948.
100. Kelley D.E., Thaete F.L., Troost F., et al. Subdivisions of subcutaneous abdominal adipose tissue and insulin resistance. Am J Physiol Endocrinol Metab. 278:(5):2000;E941.
101. Smith S.R., Lovejoy J.C., Greenway F., et al. Contributions of total body fat, abdominal subcutaneous adipose tissue compartments, and visceral adipose tissue to the metabolic complications of obesity. Metabolism. 50:(4):2001;425.
102. Monzon J.R., Basile R., Heneghan S., Udupi V., Green A. Lipolysis in adipocytes isolated from deep and superficial subcutaneous adipose tissue. Obes Res. 10:2002;266.
103. Huang T.T., Johnson M.S., Figueroa-Colon R., et al. Growth of visceral fat, subcutaneous abdominal fat, and total body fat in children. Obes Res. 9:2001;283.
104. Garaulet M., Perex-Llamas F., Fuente T., et al. Anthropometric, computed tomography and fat cell data in an obese population relationship with insulin, leptin, tumour necrosis factor-alpha, sex hormone-binding globulin and sex hormones. Eur J Endocrinol. 143:2000;657.
105. Reynisdottir S., Dauzats M., Thorne A. Comparison of hormone-sensitive lipase activity in visceral and subcutaneous adipose tissue. J Clin Endocrinol Metab. 82:1997;4162.
106. Weyer C., Foley J.E., Bogardus C., et al. Enlarged subcutaneous abdominal adipocyte size, but not obesity itself, predicts type II diabetes independent of insulin resistance. Diabetologia. 43:2000;1498.
107. Imbeault P., Lemieux S., Prud'homme D. Relationship of visceral adipose tissue to metabolic risk factors for coronary heart disease is there a contribution of subcutaneous fat cell hypertrophy? Metabolism. 48:1999;355.
108. Despres J.P., Fong B.S., Julien P., et al. Regional variation in HDL metabolism in human cells effect of cell size. Am J Physiol. 252:(5, pt 1):1987;E654.
109. Minocci A., Savia G., Lucantoni R., et al. Leptin plasma concentrations are dependent on body fat distribution in obese patients. Int J Obes Relat Metab Disord. 24:2000;1139.
110. Johannsson G., Karlsson C., Lonn L., et al. Serum leptin concentration and insulin sensitivity in men with abdominal obesity. Obes Res. 6:1998;416.
111. Shimizu H., Shimomura Y., Hayashi R., et al. Serum leptin concentration is associated with total body fat mass, but not abdominal fat distribution. Int J Obes Relat Metab Disord. 21:1997;536.
112. Sudi K.M., Gallistl S., Tafeit E., et al. The relationship between different subcutaneous adipose tissue layers, fat mass and leptin in obese children and adolescents. J Pediatr Endocrinol Metab. 13:(5):2000;505.
113. Cnop M., Landchild M.J., Vidal J., et al. The concurrent accumulation of intra-abdominal and subcutaneous fat explains the association between insulin resistance and plasma leptin concentrations distinct metabolic effects of two fat compartments. Diabetes. 51:2002;1005.
114. Hube F., Lietz U., Igel M., et al. Differences in leptin mRNA levels between omental and subcutaneous adipose tissue from humans. Horm Metab Res. 28:1996;690.
115. Dusserre E., Moulin P., Vidal H. Differences in mRNA expression of proteins secreted by adipocytes in human subcutaneous and visceral adipose tissue. Biochim Biophys Acta. 1500:2000;88.
116. Zhang H.H., Kumar S., Barnett A.H., et al. Intrinsic site-specific differences in the expression of leptin in human adipocytes and its autocrine effects on glucose uptake. J Clin Endocrinol Metab. 84:1999;2550.
117. 3-adrenergic receptor mRNA in man. J Clin Invest. 91:1993;344.
118. 3-adrenoceptors in obesity. J Clin Invest. 95:1995;1109.
119. Zierath J.R., Livingston J.N., Thorne A., et al. Regional differences in insulin inhibition of non-esterified fatty acid release from human adipocytes relation to insulin receptor phosphorylation and intracellular signaling through the insulin receptor substrate-1 pathway. Diabetologia. 41:1998;1343.
120. Bonadonna R., Bonora E. Glucose and free fatty acid metabolism in human obesity. Diabetes Rev. 5:1997;21.
121. Maslowska M.H., Sniderman A.D., MacLean L.D., Cianflone K. Regional differences in triacylglycerol synthesis in adipose tissue and in cultured preadipocytes. J Lipid Res. 34:1993;219.
122. Fried S.K., Russell C.D., Grauso N.L., Brolin R.E. Lipoprotein lipase regulation by insulin and glucocorticoid in subcutaneous and omental adipose tissues of obese women and men. J Clin Invest. 92:1993;2191.
123. Arner P. Catecholamine-induced lipolysis in obesity. Int J Obes Relat Metab Disord. 23:(suppl 1):1999;10.
124. Marin P., Andersson B., Ottosson M., et al. The morphology and metabolism of intraabdominal adipose tissue in men. Metabolism. 41:1992;1242.
125. Hoffstedt J., Wahrenberg H., Thorne A., et al. The metabolic syndrome is related to beta 3-adrenoreceptor sensitivity in visceral adipose tissue. Diabetologia. 39:1996;838.
126. Imbeault P., Couillard C., Tremblay A., et al. Reduced alpha (2)-adrenergic sensitivity of subcutaneous abdominal adipocytes as a modulator of fasting and post-prandial triglyceride levels in men. J Lipid Res. 41:2000;1367.
127. Marin P., Oden B., Bjorntorp P. Assimilation and mobilization of triglycerides in subcutaneous abdominal and femoral adipose tissue in vivo in men effects of androgens. J Clin Endocrinol Metab. 80:1995;239.
128. Martin M.L., Jensen M.D. Effects of body distribution on regional lipolysis in obesity. J Clin Invest. 88:1991;609.
129. Tchkonia T., Giorgadze N., Pirtskhalava T., et al. Fat depot origin affects adipogenesis in primary cultured and cloned human preadipocytes. Am J Physiol Regul Intergr Comp Physiol. 282:(5):2002;R1286.
130. Marette A., Mauriege P., Marcotte B., et al. Regional variation in adipose tissue insulin action and GLUT4 transporter expression in severely obese premenopausal women. Diabetologia. 40:1997;590.
131. McTernan P.G., McTernan C.L., Chetty R., et al. Increased resistin gene and protein expression in human abdominal adipose tissue. J Clin Endocrinol Metab. 87:2002;2407.
132. McTernan C.L., McTernan P.G., Harte A.L., et al. Resistin, central obesity, and type 2 diabetes. Lancet. 359:(9300):2002;46.
133. Yamauchi T., Kamon J., Waki H., et al. The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity. Nat Med. 7:2001;941.
134. Statnick M.A., Beavers L.S., Conner L.J., et al. Decreased expression of apM1 in omental and subcutaneous adipose tissue of humans with type 2 diabetes. Int J Exp Diabetes Res. 1:(2):2000;81.
135. Gottschling-Zeller H., Birgel M., Rohrig K., et al. Effect of tumor necrosis factor alpha and transforming growth factor beta 1 on plasminogen activator inhibitor-1 secretion from subcutaneous and omental human fat cells in suspension cultures. Metabolism. 49:2000;666.
136. Polac I., Cierniewska-Cieslak A., Stachowiak G., et al. Similar PAI-1 expression in visceral and subcutaneous fat of postmenopausal women. Thromb Res. 102:(5):2001;397.
137. Giltay E.J., Elbers J.M., Gooren L.J., et al. Visceral fat accumulation is an important determinant of PAI-1 levels in young, nonobese men and women modulation by cross-sex hormone administration. Arterioscler Thromb Vasc Biol. 18:(11):1998;1716.
138. Engeli S., Gorzelniak K., Kreutz R., et al. Co-expression of renin-angiotensin system genes in human adipose tissue. J Hypertens. 17:(4):1999;555.
139. Giacchetti G., Faloia E., Sardu C., et al. Gene expression of angiotensinogen in adipose tissue of obese patients. Int J Obes Relat Metab Disord. 24:(suppl 2):2000;S142.
140. Joyner J.M., Hutley L.J., Cameron D.P. Glucocorticoid receptors in human preadipocytes regional and gender variations. J Endocrinol. 166:(1):2000;145.
141. van Harmelen V., Elizalde M., Ariapaert P., et al. The association of human adipose tissue angiotensinogen gene expression with abdominal fat distribution in obesity. Int J Obes Relat Metab Disord. 24:2000;673.
142. Mohamed-Ali V., Pinkney J.H., Coppack S.W. Adipose tissue as an endocrine and paracrine organ. Int J Obes Relat Metab Disord. 22:1998;1145.
143. Hube F., Birgel M., Lee Y.M., Hauner H. Expression pattern of tumour necrosis factor receptors in subcutaneous and omental human adipose tissue role of obesity and non-insulin-dependent diabetes mellitus. Eur J Clin Invest. 29:1999;672.
144. Fried S.K., Bunkin D.A., Greenberg A.S. Omental and subcutaneous adipose tissues of obese subjects release interleukin-6 depot difference and regulation by glucocorticoid. J Clin Endocrinol Metab. 83:1998;847.
145. Pedersen S.B., Hansen P.S., Lund S., et al. Identification of oestrogen receptors and oestrogen receptor mRNA in human adipose tissue. Eur J Clin Invest. 26:1996;259.
146. McTernan P.G., Anderson L.A., Anwar A.J., et al. Glucocorticoid regulation of p450 aromatase activity in human adipose tissue gender and site differences. J Clin Endocrinol Metab. 87:2002;1327.
147. Ryden M., Elizalde M., van Harmelen V., et al. Increased expression of eNOS protein in omental Vs subcutaneous adipose tissue in obese human subjects. Int J Obes Relat Metab Disord. 25:2001;811.
148. Lonnqvist F., Thorne A., Large V., Arner P. Sex differences in visceral fat lipolysis and metabolic complications of obesity. Arterioscler Thromb Vasc Biol. 17:1997;1472.
149. Seufert J., Keiffer T.J., Leech C.A., et al. Leptin suppression of insulin secretion and gene expression in human pancreatic islets implications for development of adipogenic diabetes mellitus. J Clin Endocrinol Metab. 84:1999;670.
150. Kirchgessner T.G., Uysal T., Wiesbrock S.M., Marino M.W., Hotamisligil G. Tumour necrosis factor-alpha contributes to obesity related hypoleptinemia by regulating leptin release from adipocytes. J Clin Invest. 100:1997;2777.
151. Wabitsch M., Hauner H., Heinze H., et al. Body fat distribution and changes in atherogenic risk-factor profile in obese adolescent girls during weight reduction. Am J Clin Nutr. 60:1994;54.
152. Fujioka S., Matsuzawa Y., Tokunaga K., et al. Improvement in glucose and lipid metabolism associated with selective reduction of intra-abdominal visceral fat in pre-menopausal women with visceral fat obesity. Int J Obes. 15:(12):1991;853.
153. Schwartz R.S., Shuman W.P., Larson V., et al. The effect of intensive endurance exercise training on body fat distribution in young and older men. Metabolism. 40:1991;545.
154. Despres J.P., Pouliot M.C., Moorjani S., et al. Loss of abdominal fat and metabolic response to exercise training in obese women. Am J Physiol. 24:1991;159.
155. Ross R., Dagnone D., Jones P.J.H., et al. Reduction in obesity and related comorbid conditions after diet-induced weight loss or exercise-induced weight loss in men. Ann Intern Med. 133:2000;92.
156. Anderssen S.A., Holme I., Urdal P., et al. Association of central obesity and indexes of hemostatic, carbohydrate and lipid metabolism. Result of 1-year intervention from Oslo Diet and Exercise Study. Scand J Med Sci Sports. 8:(2):1998;109.
157. Ross R., Janssen I. Physical activity, total and regional obesity dose-response considerations. Med Sci Sports Exerc. 33:(suppl):2001;S521.
158. Buemann B., Tremblay A. Effects of exercise training on abdominal obesity and related metabolic complications. Sports Med. 21:1996;191.
159. Marks S.J., Moore N.R., Clark M.L., et al. Reduction in visceral adipose tissue and improvement in metabolic indices effect of dexfenfluramine in NIDDM. Obes Res. 4:(1):1996;77.
160. Pasquali R., Gambineri A., Biscoff D., et al. Effect of long term treatment with metformin added to hypocaloric diet on body composition, fat distribution and androgen and insulin levels in abdominally obese women with and without the polycystic ovary syndrome. J Clin Endocrinol Metab. 85:2000;2767.
161. de Souza C.J., Eckhardt M., Gagen K., et al. Effects of pioglitazone on adipose tissue remodeling within the setting of obesity and insulin resistance. Diabetes. 50:2001;1863.
162. Karhunen L., Franssila-Kallunki A., Rissanen P., et al. Effect of orlistat treatment on body composition and resting energy expenditure during a two-year weight-reduction programme in obese Finns. Int J Obes. 24:2000;1567.
163. Kelly I.E., Han T.S., Walsh K., Lean M.E. Effects of a thiazolidinediones compound on body fat and fat distribution of patients with type 2 diabetes. Diabetes Care. 22:1999;288.
164. Mayerson A.B., Hundal R.S., Dufour S., et al. The effects of rosiglitazone on insulin sensitivity, lipolysis, and hepatic and skeletal muscle triglyceride content in patients with type 2 diabetes. Diabetes. 51:2002;797.
165. Richelsen B., Pedersen S.B., Borglum J.D., et al. Growth hormone treatment of obese women for 5 wk effect on body composition and adipose tissue LPL activity. Am J Physiol. 266:(2, pt 1):1994;E211.
166. Rebuffe-Scrive M., Marin P., Bjorntorp P. Effect of testosterone on abdominal adipose tissue in men. Int J Obes. 15:(11):1991;791.
167. Purnell J.Q., Kahn S.E., Albers J.J., et al. Effect of weight loss with reduction of intra-abdominal fat on lipid metabolism in older men. J Clin Endocrinol Metab. 85:2000;977.
168. Barzilai N., She L., Liu B.Q., et al. Surgical removal of visceral fat reverses hepatic insulin resistance. Diabetes. 48:1999;94.
169. Giese S.Y., Bulan E.J., Commons G.W., Spear S.L., Yanovski J.A. Improvements in cardiovascular risk profile with large-volume liposuction a pilot study. Plast Reconstr Surg. 108:(2):2001;510.
170. Samdal F., Birkeland K.I., Ose L., Amland P.F. Effect of large-volume liposuction on sex hormones and glucose- and lipid metabolism in females. Aesthetic Plast Surg. 19:(2):1995;131.
171. Berntorp E., Berntorp K., Brorson H., Frick K. Liposuction in Dercum's disease impact on haemostatic factors associated with cardiovascular disease and insulin sensitivity. J Intern Med. 243:1998;197.